T. Mayo, “Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials”, J of Skin, vol. 7, no. 2, p. s141, Mar. 2023.